Haematococcus Pluvialis Market to Reach $189.8 Million by 2030


Posted December 27, 2023 by shubham01

Haematococcus Pluvialis Market by Product (Astaxanthin Ingredients {Oleoresin, Beadlets}), Astaxanthin Bulk Finished Products {Capsules, Tablets}); Application (Nutraceuticals, Aquaculture, Cosmetics, Food), and Geography -
 
Meticulous Research®—a leading global market research company, published a research report titled ‘Haematococcus Pluvialis Market by Product (Astaxanthin Ingredients {Oleoresin, Beadlets}), Astaxanthin Bulk Finished Products {Capsules, Tablets}); Application (Nutraceuticals, Aquaculture, Cosmetics, Food), and Geography - Global Forecast to 2030’.

According to this latest publication from Meticulous Research®, based on value, the haematococcus pluvialis market is projected to reach $189.8 million by 2030, at a CAGR of 13.3% from 2023 to 2030. In terms of volume, this market is projected to reach 1,369.9 tons by 2030, at a CAGR of 14.8% from 2023 to 2030.

Download Sample Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5142

The growth of this market is driven by increasing demand for natural astaxanthin for nutraceuticals, growing natural food colorant’s demand, and awareness about clean-label products. However, the high production cost is expected to restrain the growth of this market.

The growing demand for natural astaxanthin and the use of natural astaxanthin in poultry and aquaculture are expected to create market growth opportunities. However, the complex production process of haematococcus pluvialis is a major challenge for the players operating in this market. Additionally, the increasing need for self-grooming products is a prominent trend in the global haematococcus pluvialis market.

Browse the In-depth Report on:

The global haematococcus pluvialis market is segmented by product (astaxanthin ingredients {astaxanthin oleoresin, beadlets, whole biomass powder, water dispersible powder}), astaxanthin bulk finished products {capsules/softgels, tablets}); application (nutraceuticals, aquaculture & animal feed, cosmetics, food & beverages, pharmaceuticals); and geography (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa). The study also evaluates industry competitors and analyzes the regional and country-level markets.

Based on product, in 2023, the astaxanthin ingredients segment is expected to account for the largest share of the global haematococcus pluvialis market. The large market share of this segment is mainly attributed to the growing end-use applications of the astaxanthin ingredients, rising awareness about preventive healthcare & nutraceuticals, incresing demand for natural antioxidants, growing cosmetic & personal care markets, and government initiatives to support the aquaculture industry.

Based on application, in 2023, the nutraceuticals segment is expected to account for the largest share of the global haematococcus pluvialis market. The large market share of this segment is mainly attributed to the increasing demand for natural astaxanthin derived from haematococcus in the nutraceuticals industry due to its potential effects on various diseases, including cancers, hypertension, diabetes, cardiovascular, gastrointestinal, and liver neurodegenerative, and several skin diseases.

Speak to Analyst:- https://www.meticulousresearch.com/speak-to-analyst/cp_id=5142

Based on geography,This research report analyzes major geographies and provides a comprehensive analysis of North America (the U.S. and Canada), Europe (Germany, U.K., Italy, France, Sweden, Spain, Russia, Netherlands, Denmark, Poland, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea Vietnam and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, and Rest of Latin America), and the Middle East & Africa (Israel, Egypt, Saudi Arabia, South Africa, UAE, and Rest of Middle East & Africa).

In 2023, North America is expected to account for the largest share of the global haematococcus pluvialis market, followed by Asia-Pacific and Europe. The large share of this market is primarily attributed to the increasing demand for natural food supplements and growing awareness about the adverse effects of chemical products among consumers. In addition, several awareness programs by various organizations are estimated to upsurge the regional market share. For instance, the Natural Algae Astaxanthin Association (NAXA) is focused on increasing awareness about astaxanthin usage. Further, haematococcus pluvialis algae have been approved for use as a dietary supplement ingredient in the U.S., and Canada is one of the major factors contributing to the growth of haematococcus pluvialis in North America.

Key Players:

The haematococcus pluvialis market is characterized by a moderately competitive scenario due to the presence of many large- and small-sized global, regional, and local players. The key players operating in the haematococcus pluvialis market are E.I.D. - Parry (India) Limited (A Subsidiary of M/S. Ambadi Investments Limited) (India), Cyanotech Corporation (U.S.), YUNNAN GREEN A BIOLOGICAL PROJECT CO., LTD. (Yunnan Spirin Biotechnology Co. Ltd) (China), Sun Chlorella Corporation (Japan), Roquette Klötze GmbH & Co. KG (Germany), Tianjin Norland Biotech Co., Ltd (China), Aliga Microalgae (Denmark), DAESANG Corporation (Korea), Plankton Australia Pty Limited (Australia), Shaanxi Rebecca Bio-Tech Co., Ltd (China), BlueBioTech Group (Germany), Algatechnologies Ltd. (A Part of Solabia Group) (Israel), AstaReal Group (Japan), Yunnan Alphy Biotech Co.,Ltd (China), Beijing Gingko Group (BGG) (U.S.), FENCHEM (China), PIVEG, Inc. (U.S.), Algamo s.r.o. (Czech Republic), Algalíf Iceland ehf. (Part of Sana Pharma Industries) (Iceland), Atacama Bio Natural Products S.A. (Chile), BDI BioLife Science GmbH (Austria), AstaMAZ NZ LTD (New Zealand), FjordAlg AS (Norway), Sea & Sun Organic GmbH (Subsidiary of Sea & Sun Technology GmbH) (Germany), MC Biotech Sdn. Bhd. (Brunei Darussalam), Pond Technologies Inc. (Canada), Algicel, Biotecnologia e Investigação, Lda (Portugal), Algae to Omega, LLC (U.S.), Shaivaa Algaetech LLP (India), and Astaxa GmbH (Germany).

Quick Buy:- https://www.meticulousresearch.com/Checkout/24697412

Key Questions Answered in the Report-

What is the current value of revenue generated by the global haematococcus pluvialis market?
At what rate is the global demand for haematococcus pluvialis projected to grow for the next 5-7 years?
What is the historical market size and growth rate for the haematococcus pluvialis market?
What are the major factors impacting the growth of this market at global and regional levels? What are the major opportunities for existing players and new entrants in the market?
Which product and application segments create major traction for the manufacturers in this market?
What are the key geographical trends in this market? Which regions/countries are likely to offer significant growth opportunities for the manufacturers in this market during the analysis period?
Who are the major players in the haematococcus pluvialis market? What are their specific product offerings in this market?
What recent developments have taken place in the haematococcus pluvialis market? What impact have these strategic developments created on the market?
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By [email protected]
Phone 07447780008
Business Address Office No-202, 203,204,205,206; 2nd Floor, Pushpak Business Hub, Pune, Wakad, Pimpri-Chinchwad, Maharashtra 411057
Office No-202, 203,204,205,206
Country India
Categories Biotech , Business , Health
Tags haematococcus , haematococcus pluvialis market , haematococcus pluvialis microalgae , astazanthin , haematococcus pluvialis astaxanthin
Last Updated December 27, 2023